Quantum量子訊息有限公司

Recombinant Vaccine CDMO Market

研究執行與發布：Grand View Research　·　發布日期 2026-08-28　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

申請 Sample
完整報告名稱與涵蓋範圍
Recombinant Vaccine CDMO Market Size, Share & Trends Analysis Report By Vaccine, By Service (Contract Development, Regulatory Affairs), By Expression Platform, By Workflow (Clinical, Commercial), By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2026 - 2033

報告摘要

Recombinant Vaccine CDMO Market Summary The global recombinant vaccine CDMO market size was valued at USD 5.6 billion in 2025 and is projected to grow from USD 6.1 billion in 2026 to USD 12.4 billion by 2033, at a CAGR of 10.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 43.8% in 2025. Market growth is driven by increasing demand for recombinant protein vaccines, expansion of vaccine development pipelines, and growing outsourcing of vaccine development and manufacturing activities. Moreover, the need for specialized capabilities in recombinant antigen expression, upstream and downstream processing, formulation, and fill-finish services is increasing the demand for CDMO services. Technological advancements in recombinant expression systems, cell line development, process optimization, automation, and analytical testing are improving manufacturing efficiency, product consistency, and scalability. Furthermore, the vaccine industry has witnessed continued growth in recent years, supported by increasing vaccine development activities and advances in recombinant protein technologies. The growing number of recombinant vaccine candidates across infectious disease indications is increasing demand for specialized development and manufacturing capabilities. These products require controlled antigen expression, purification, formulation, analytical characterization, and GMP-compliant manufacturing processes. Thus, the expansion of recombinant vaccine development pipelines is expected to increase demand for specialized CDMO services in the coming years. In addition, several pharmaceutical and biotechnology companies are increasingly outsourcing recombinant vaccine development and manufacturing activities to specialized CDMOs due to the technical expertise, specialized infrastructure, and capital requirements associated with in-house production. CDMOs provide process development, expression system optimization, scale-up, GMP manufacturing, analytical testing, formulation, and fill-finish services. This approach enables vaccine developers to access specialized manufacturing capabilities while reducing the need to establish dedicated production facilities. The trend is particularly relevant among emerging biotechnology companies progressing recombinant vaccine candidates through clinical development and requiring flexible manufacturing capacity. Global Recombinant Vaccine CDMO Market Report Segmentation This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global recombinant vaccine CDMO market report based on vaccine, service, expression platform, workflow, therapeutic area, end-use, and region: • Vaccine Outlook (Revenue, USD Billion, 2021 - 2033) • Recombinant Protein/Subunit Vaccines • Virus-Like Particle (VLP) Vaccines • Recombinant Viral Vector Vaccines • Recombinant DNA/mRNA-enabled Vaccines • Others • Service Outlook (Revenue, USD Billion, 2021 - 2033) • Contract Development o Cell Line Development o Process Development & Optimization o Analytical Testing & Method Validation o Scale-up & Tech Transfer • Contract Manufacturing o API Manufacturing o Finished Drug Products Manufacturing • Packaging and Labeling • Regulatory Affairs • Others • Expression Platform Outlook (Revenue, USD Billion, 2021 - 2033) • Mammalian Cell Expression • Microbial Expression • Cell-Based Expression • Plant-Based Expression • Others • Workflow (Revenue, USD Billion, 2021 - 2033) • Clinical • Commercial • Therapeutic Area (Revenue, USD Billion, 2021 - 2033) • Infectious Diseases • Oncology • Neurological Disorders • Other Applications • End-use Outlook (Revenue, USD Billion, 2021 - 2033) • Pharmaceutical Companies • Biotechnology Companies • Academic and Research Institutions • Others • Regional Outlook (Revenue, USD Billion, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Sweden o Norway o Denmark • Asia Pacific o Japan o China o India o South Korea o Australia o Thailand • Latin America o Brazil o Argentina • Middle East & Africa o South Africa o Saudi Arabia o UAE o Kuwait o Oman o Qatar

授權報價

Single User License$5,950 USD
Enterprise License$6,950 USD
Corporate User License$8,950 USD

目錄 Table of Contents

Table of Contents Chapter 1. Research Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Vaccine 1.2.2. Service 1.2.3. Expression Platform 1.2.4. Workflow 1.2.5. Therapeutic Area 1.2.6. End Use 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. GVR’s Internal Database 1.4.3. Secondary Sources 1.4.4. Primary Research 1.5. Information Or Data Analysis 1.5.1. Data Analysis Models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity Flow Analysis 1.7.2. Top-Down Analysis 1.7.3. Botton-Up Approach 1.7.4. Multivariate Analysis 1.8. List of Secondary Sources 1.9. List of Abbreviations 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights Chapter 3. Recombinant Vaccine CDMO Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.2. Market Restraint Analysis 3.3. Technology Landscape 3.4. Pricing Model Analysis 3.5. Tariff Impact Analysis 3.6. Value Chain Analysis 3.6.1. Supply Trends 3.6.2. Demand Trends 3.7. Market Analysis Tools 3.7.1. Porter’s Five Force Analysis 3.7.2. PESTEL Analysis Chapter 4. Recombinant Vaccine CDMO Market: Vaccine Estimates & Trend Analysis 4.1. Vaccine Market Share, 2025 & 2033 4.2. Vaccine Segment Dashboard 4.3. Recombinant Vaccine CDMO Market: Vaccine Movement Analysis 4.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Vaccine, 2021 to 2033 (USD Billion) 4.5. Recombinant Protein/Subunit Vaccines 4.5.1. Recombinant Protein/Subunit Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 4.6. Virus-Like Particle (VLP) Vaccines 4.6.1. Virus-Like Particle (VLP) Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 4.7. Recombinant Viral Vector Vaccines 4.7.1. Recombinant Viral Vector Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 4.8. Recombinant DNA/mRNA-enabled Vaccines 4.8.1. Recombinant DNA/mRNA-enabled Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 4.9. Others 4.9.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Billion) Chapter 5. Recombinant Vaccine CDMO Market: Service Estimates & Trend Analysis 5.1. Service Market Share, 2025 & 2033 5.2. Service Segment Dashboard 5.3. Recombinant Vaccine CDMO Market: Service Movement Analysis 5.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Billion) 5.5. Contract Development 5.5.1. Contract Development Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.5.2. Cell Line Development 5.5.2.1. Cell Line Development Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.5.3. Process Development & Optimization 5.5.3.1. Process Development & Optimization Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.5.4. Analytical Testing & Method Validation 5.5.4.1. Analytical Testing & Method Validation Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.5.5. Scale-up & Tech Transfer 5.5.5.1. Scale-up & Tech Transfer Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.6. Contract Manufacturing 5.6.1. Contract Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.6.2. API Manufacturing 5.6.2.1. API Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.6.3. Finished Drug Products Manufacturing 5.6.3.1. Finished Drug Products Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.7. Packaging and Labeling 5.7.1. Packaging and Labeling Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.8. Regulatory Affairs 5.8.1. Regulatory Affairs Market Estimates & Forecasts, 2021 to 2033 (USD Billion) 5.9. Others 5.9.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Billion) Chapter 6. Recombinant Vaccine CDMO Market: Expression Platform Estimates & Trend Analysis 6.1. Expression Platform Market Share, 2025 & 2033 6.2. Expression Platform Segment Dashboard 6.3. Global Recombinant Vaccine CDMO Market: Expression Platform Movement Analysis 6.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Expression Platform, 2021 to 2033 (USD Billion) 6.5. Mammalian Cell Expression 6.5.1. Mammalian Cell Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 6.6. Microbial Expression 6.6.1. Microbial Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 6.7. Cell-Based Expression 6.7.1. Cell-Based Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 6.8. Plant-Based Expression 6.8.1. Plant-Based Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 6.9. Others 6.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Billion) Chapter 7. Recombinant Vaccine CDMO Market: Workflow Estimates & Trend Analysis 7.1. Workflow Market Share, 2025 & 2033 7.2. Workflow Platform Segment Dashboard 7.3. Global Recombinant Vaccine CDMO Market: Workflow Movement Analysis 7.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Billion) 7.5. Clinical 7.5.1. Clinical Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 7.6. Commercial 7.6.1. Commercial Market Estimates & Forecasts, 2021 - 2033 (USD Billion) Chapter 8. Recombinant Vaccine CDMO Market: Therapeutic Area Estimates & Trend Analysis 8.1. Therapeutic Area Market Share, 2025 & 2033 8.2. Therapeutic Area Segment Dashboard 8.3. Global Recombinant Vaccine CDMO Market: Therapeutic Area Movement Analysis 8.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Billion) 8.5. Infectious Diseases 8.5.1. Infectious Diseases Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 8.6. Oncology 8.6.1. Oncology Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 8.7. Neurological Disorders 8.7.1. Neurological Disorders Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 8.8. Other Applications 8.8.1. Other Applications Market Estimates & Forecasts, 2021 - 2033 (USD Billion) Chapter 9. Recombinant Vaccine CDMO Market: End Use Estimates & Trend Analysis 9.1. End Use Market Share, 2025 & 2033 9.2. End Use Segment Dashboard 9.3. Recombinant Vaccine CDMO Market: End Use Movement Analysis 9.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion) 9.5. Pharmaceutical Companies 9.5.1. Pharmaceutical Companies Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 9.6. Biotechnology Companies 9.6.1. Biotechnology Companies Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 9.7. Academic and Research Institutions 9.7.1. Academic and Research Institutions Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 9.8. Others 9.8.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Billion) Chapter 10. Recombinant Vaccine CDMO Market: Regional Estimates & Trend Analysis 10.1. Regional Market Dashboard 10.2. Recombinant Vaccine CDMO Market: Regional Movement Analysis 10.3. Market Size & Forecasts Trend Analysis, 2021 to 2033 10.4. North America 10.4.1. North America Recombinant Vaccine CDMO Market Estimates & Forecasts, By Country, 2021-2033 (USD Billion) 10.4.2. U.S. 10.4.2.1. Key Country Dynamics 10.4.2.2. Regulatory Framework 10.4.2.3. U.S. Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.4.3. Canada 10.4.3.1. Key Country Dynamics 10.4.3.2. Regulatory Framework 10.4.3.3. Canada Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.4.4. Mexico 10.4.4.1. Key Country Dynamics 10.4.4.2. Regulatory Framework 10.4.4.3. Mexico Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5. Europe 10.5.1. Europe Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.2. UK 10.5.2.1. Key Country Dynamics 10.5.2.2. Regulatory Framework 10.5.2.3. UK Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.3. Germany 10.5.3.1. Key Country Dynamics 10.5.3.2. Regulatory Framework 10.5.3.3. Germany Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.4. France 10.5.4.1. Key Country Dynamics 10.5.4.2. Regulatory Framework 10.5.4.3. France Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.5. Italy 10.5.5.1. Key Country Dynamics 10.5.5.2. Regulatory Framework 10.5.5.3. Italy Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.6. Spain 10.5.6.1. Key Country Dynamics 10.5.6.2. Regulatory Framework 10.5.6.3. Spain Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.7. Denmark 10.5.7.1. Key Country Dynamics 10.5.7.2. Regulatory Framework 10.5.7.3. Denmark Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.8. Sweden 10.5.8.1. Key Country Dynamics 10.5.8.2. Regulatory Framework 10.5.8.3. Sweden Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.5.9. Norway 10.5.9.1. Key Country Dynamics 10.5.9.2. Regulatory Framework 10.5.9.3. Norway Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6. Asia Pacific 10.6.1. Asia Pacific Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.2. Japan 10.6.2.1. Key Country Dynamics 10.6.2.2. Regulatory Framework 10.6.2.3. Japan Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.3. China 10.6.3.1. Key Country Dynamics 10.6.3.2. Regulatory Framework 10.6.3.3. China Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.4. India 10.6.4.1. Key Country Dynamics 10.6.4.2. Regulatory Framework 10.6.4.3. India Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.5. Australia 10.6.5.1. Key Country Dynamics 10.6.5.2. Regulatory Framework 10.6.5.3. Australia Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.6. South Korea 10.6.6.1. Key Country Dynamics 10.6.6.2. Regulatory Framework 10.6.6.3. South Korea Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.6.7. Thailand 10.6.7.1. Key Country Dynamics 10.6.7.2. Regulatory Framework 10.6.7.3. Thailand Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.7. Latin America 10.7.1. Latin America Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.7.2. Brazil 10.7.2.1. Key Country Dynamics 10.7.2.2. Regulatory Framework 10.7.2.3. Brazil Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.7.3. Argentina 10.7.3.1. Key Country Dynamics 10.7.3.2. Regulatory Framework 10.7.3.3. Argentina Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8. Middle East and Africa 10.8.1. Middle East and Africa Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Billion) 10.8.2. South Africa 10.8.2.1. Key Country Dynamics 10.8.2.2. Regulatory Framework 10.8.2.3. South Africa Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8.3. Saudi Arabia 10.8.3.1. Key Country Dynamics 10.8.3.2. Regulatory Framework 10.8.3.3. Saudi Arabia Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8.4. UAE 10.8.4.1. Key Country Dynamics 10.8.4.2. Regulatory Framework 10.8.4.3. UAE Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8.5. Kuwait 10.8.5.1. Key Country Dynamics 10.8.5.2. Regulatory Framework 10.8.5.3. Kuwait Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8.6. Oman 10.8.6.1. Key Country Dynamics 10.8.6.2. Regulatory Framework 10.8.6.3. Oman Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) 10.8.7. Qatar 10.8.7.1. Key Country Dynamics 10.8.7.2. Regulatory Framework 10.8.7.3. Qatar Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion) Chapter 11. Competitive Landscape 11.1. Participant Overview 11.2. Company Market Position Analysis 11.3. Company Categorization 11.4. Strategy Mapping 11.5. Company Profiles/Listing 11.5.1. FUJIFILM Biotechnologies 11.5.1.1. Company overview 11.5.1.2. Financial performance 11.5.1.3. Service benchmarking 11.5.1.4. Strategic initiatives 11.5.2. WuXi Biologics 11.5.2.1. Company overview 11.5.2.2. Financial performance 11.5.2.3. Service benchmarking 11.5.2.4. Strategic initiatives 11.5.3. IDT Biologika 11.5.3.1. Company overview 11.5.3.2. Financial performance 11.5.3.3. Service benchmarking 11.5.3.4. Strategic initiatives 11.5.4. Lonza 11.5.4.1. Company overview 11.5.4.2. Financial performance 11.5.4.3. Service benchmarking 11.5.4.4. Strategic initiatives 11.5.5. Thermo Fisher Scientific (Patheon) 11.5.5.1. Company overview 11.5.5.2. Financial performance 11.5.5.3. Service benchmarking 11.5.5.4. Strategic initiatives 11.5.6. AGC Biologics 11.5.6.1. Company overview 11.5.6.2. Financial performance 11.5.6.3. Service benchmarking 11.5.6.4. Strategic initiatives 11.5.7. KBI Biopharma 11.5.7.1. Company overview 11.5.7.2. Financial performance 11.5.7.3. Service benchmarking 11.5.7.4. Strategic initiatives 11.5.8. Ajinomoto Bio-Pharma Services 11.5.8.1. Company overview 11.5.8.2. Financial performance 11.5.8.3. Service benchmarking 11.5.8.4. Strategic initiatives 11.5.9. Northway Biotech 11.5.9.1. Company overview 11.5.9.2. Financial performance 11.5.9.3. Service benchmarking 11.5.9.4. Strategic initiatives 11.5.10. Batavia Biosciences 11.5.10.1. Company overview 11.5.10.2. Financial performance 11.5.10.3. Service benchmarking 11.5.10.4. Strategic initiatives 11.5.11. Recipharm 11.5.11.1. Company overview 11.5.11.2. Financial performance 11.5.11.3. Service benchmarking 11.5.11.4. Strategic initiatives 11.5.12. 3P Biopharmaceuticals 11.5.12.1. Company overview 11.5.12.2. Financial performance 11.5.12.3. Service benchmarking 11.5.12.4. Strategic initiatives 11.5.13. Biofabri 11.5.13.1. Company overview 11.5.13.2. Financial performance 11.5.13.3. Service benchmarking 11.5.13.4. Strategic initiatives 11.5.14. Biological E. Limited 11.5.14.1. Company overview 11.5.14.2. Financial performance 11.5.14.3. Service benchmarking 11.5.14.4. Strategic initiatives 11.5.15. SK bioscience 11.5.15.1. Company overview 11.5.15.2. Financial performance 11.5.15.3. Service benchmarking 11.5.15.4. Strategic initiatives

圖表清單 List of Tables & Figures

List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 4 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 5 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 6 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 7 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 8 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 9 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion) Table 10 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 11 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 12 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 13 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 14 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 15 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 16 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 17 U.S.Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 18 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 19 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 20 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 21 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 22 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 23 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 24 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 25 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 26 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 27 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 28 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 29 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 30 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 31 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 32 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 33 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 34 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion) Table 35 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 36 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 37 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 38 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 39 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 40 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 41 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 42 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 43 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 44 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 45 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 46 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 47 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 48 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 49 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 50 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 51 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 52 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 53 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 54 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 55 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 56 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 57 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 58 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 59 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 60 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 61 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 62 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 63 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 64 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 65 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 66 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 67 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 68 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 69 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 70 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 71 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 72 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 73 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 74 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 75 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 76 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 77 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 78 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 79 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 80 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 81 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 82 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 83 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 84 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 85 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 86 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 87 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 88 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 89 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion) Table 90 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 91 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 92 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 93 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 94 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 95 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 96 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 97 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 98 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 99 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 100 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 101 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 102 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 103 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 104 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 105 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 106 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 107 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 108 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 109 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 110 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 111 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 112 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 113 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 114 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 115 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 116 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 117 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 118 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 119 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 120 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 121 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 122 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 123 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 124 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 125 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 126 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 127 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 128 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 129 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 130 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 131 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 132 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion) Table 133 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 134 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 135 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 136 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 137 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 138 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 139 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 140 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 141 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 142 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 143 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 144 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 145 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 146 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 147 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 148 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 149 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 150 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 151 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion) Table 152 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 153 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 154 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 155 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 156 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 157 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 158 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 159 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 160 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 161 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 162 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 163 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 164 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 165 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 166 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 167 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 168 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 169 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 170 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 171 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 172 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 173 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 174 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 175 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 176 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 177 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 178 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 179 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 180 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 181 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 182 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 183 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 184 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 185 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 186 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 187 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) Table 188 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion) Table 189 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion) Table 190 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion) Table 191 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion) Table 192 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion) Table 193 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion) List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Market formulation & validation Fig. 6 Commodity flow analysis Fig. 7 Value-chain-based sizing & forecasting Fig. 8 QFD model sizing & forecasting Fig. 9 Bottom-up approach Fig. 10 Market snapshot Fig. 11 Segment snapshot 1 Fig. 12 Segment snapshot 2 Fig. 13 Competitive landscape snapshot Fig. 14 Parent market outlook, 2025 (USD Billion) Fig. 15 Ancillary market outlook, 2025 (USD Billion) Fig. 16 Recombinant Vaccine CDMO Market Dynamics Fig. 17 Porter’s five forces analysis Fig. 18 PESTEL analysis Fig. 19 Recombinant Vaccine CDMO Market: Vaccine outlook and key takeaways Fig. 20 Recombinant Vaccine CDMO Market: Vaccine movement analysis Fig. 21 Recombinant Protein/Subunit Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 22 Virus-Like Particle (VLP) Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 23 Recombinant Viral Vector Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 24 Recombinant DNA/mRNA-enabled Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 25 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 26 Recombinant Vaccine CDMO Market: Service outlook and key takeaways Fig. 27 Recombinant Vaccine CDMO Market: Service movement analysis Fig. 28 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 29 Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 30 Process Development & Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 31 Analytical Testing & Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 32 Scale-up & Tech Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 33 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 34 API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 35 Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 36 Packaging and Labeling Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 37 Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 38 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 39 Recombinant Vaccine CDMO Market: Expression Platform outlook and key takeaways Fig. 40 Recombinant Vaccine CDMO Market: Expression Platform movement analysis Fig. 41 Mammalian Cell Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 42 Microbial Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 43 Cell-Based Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 44 Plant-Based Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 45 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 46 Recombinant Vaccine CDMO Market: Workflow outlook and key takeaways Fig. 47 Recombinant Vaccine CDMO Market: Workflow movement analysis Fig. 48 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 49 Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 50 Recombinant Vaccine CDMO Market: Therapeutic Area outlook and key takeaways Fig. 51 Recombinant Vaccine CDMO Market: Therapeutic Area movement analysis Fig. 52 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 53 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 54 Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 55 Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 56 Recombinant Vaccine CDMO Market: End Use outlook and key takeaways Fig. 57 Recombinant Vaccine CDMO Market: End Use movement analysis Fig. 58 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 59 Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 60 Academic and Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 61 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 62 Regional Marketplace: Key Takeaways Fig. 63 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, 2018-2030 (USD Billion) Fig. 64 Key country dynamics Fig. 65 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 66 Key country dynamics Fig. 67 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 68 Key country dynamics Fig. 69 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 70 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 71 Key country dynamics Fig. 72 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 73 Key country dynamics Fig. 74 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 75 Key country dynamics Fig. 76 France Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 77 Key country dynamics Fig. 78 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 79 Key country dynamics Fig. 80 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 81 Key country dynamics Fig. 82 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 83 Key country dynamics Fig. 84 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 85 Key country dynamics Fig. 86 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 87 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 88 Key country dynamics Fig. 89 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 90 Key country dynamics Fig. 91 China Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 92 Key country dynamics Fig. 93 India Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 94 Key country dynamics Fig. 95 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 96 Key country dynamics Fig. 97 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 98 Key country dynamics Fig. 99 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 100 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 101 Key country dynamics Fig. 102 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 103 Key country dynamics Fig. 104 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 105 MEA Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 106 Key country dynamics Fig. 107 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 108 Key country dynamics Fig. 109 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 110 Key country dynamics Fig. 111 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 112 Key country dynamics Fig. 113 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 114 Key country dynamics Fig. 115 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 116 Key country dynamics Fig. 117 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion) Fig. 118 Key country dynamics Fig. 119 Participant Categorization Fig. 120 Company Market Position Analysis Fig. 121 Strategic Framework

提及公司

FUJIFILM BiotechnologiesWuXi BiologicsIDT BiologikaLonzaThermo Fisher Scientific (Patheon)AGC BiologicsKBI BiopharmaAjinomoto Bio-Pharma ServicesNorthway BiotechBatavia BiosciencesRecipharm3P BiopharmaceuticalsBiofabriBiological E. LimitedSK bioscience

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們